Dimensional Fund Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
221,322
-67,033
-23% -$528K ﹤0.01% 2799
2026
Q1
$2.22M Sell
288,355
-202,074
-41% -$1.47M ﹤0.01% 2674
2025
Q4
$3.01M Sell
490,429
-64,985
-12% -$702K ﹤0.01% 2645
2025
Q3
$10.2M Sell
555,414
-26,865
-5% -$432K ﹤0.01% 2293
2025
Q2
$7.58M Sell
582,279
-34,355
-6% -$406K ﹤0.01% 2379
2025
Q1
$6.53M Sell
616,634
-90,770
-13% -$1.44M ﹤0.01% 2413
2024
Q4
$12M Sell
707,404
-85,196
-11% -$1.6M ﹤0.01% 2229
2024
Q3
$18.4M Sell
792,600
-125,622
-14% -$2.69M ﹤0.01% 2039
2024
Q2
$22.4M Sell
918,222
-185,598
-17% -$5.63M 0.01% 1908
2024
Q1
$37.3M Buy
1,103,820
+14,890
+1% +$528K 0.01% 1657
2023
Q4
$34.3M Buy
1,088,930
+115,087
+12% +$2.74M 0.01% 1686
2023
Q3
$24.9M Buy
973,843
+278,989
+40% +$8.59M 0.01% 1804
2023
Q2
$19.9M Buy
694,854
+208,233
+43% +$5.67M 0.01% 1929
2023
Q1
$11.7M Buy
+486,621
New +$8.73M ﹤0.01% 2164
2022
Q3
$2.12M Sell
143,118
-6,274
-4% -$105K ﹤0.01% 2698
2022
Q2
$2.35M Sell
149,392
-68,180
-31% -$1.34M ﹤0.01% 2698
2022
Q1
$5.87M Buy
217,572
+142,633
+190% +$3.64M ﹤0.01% 2491
2021
Q4
$2.77M Buy
+74,939
New +$3.05M ﹤0.01% 2759

Other funds holding ARCT

Dimensional Fund Advisors's ARCT Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Arcturus Therapeutics (ARCT) stake by 23% in Q2 2026, selling an estimated $528K and leaving 221,322 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2799.

Dimensional Fund Advisors first reported a position in ARCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $37.3M in Q1 2024. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Dimensional Fund Advisors held 221,322 shares of Arcturus Therapeutics worth $1.49M as of Q2 2026.
  • Dimensional Fund Advisors sold 67,033 Arcturus Therapeutics shares in Q2 2026, an estimated $528K.
  • Arcturus Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2799 holding.
  • Dimensional Fund Advisors first reported a position in Arcturus Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Dimensional Fund Advisors's Arcturus Therapeutics position peaked at $37.3M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.